241 related articles for article (PubMed ID: 9144192)
1. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis.
Wissing D; Mouritzen H; Egeblad M; Poirier GG; Jäättelä M
Proc Natl Acad Sci U S A; 1997 May; 94(10):5073-7. PubMed ID: 9144192
[TBL] [Abstract][Full Text] [Related]
2. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease.
Cryns VL; Bergeron L; Zhu H; Li H; Yuan J
J Biol Chem; 1996 Dec; 271(49):31277-82. PubMed ID: 8940132
[TBL] [Abstract][Full Text] [Related]
3. Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation.
Atsumi G; Tajima M; Hadano A; Nakatani Y; Murakami M; Kudo I
J Biol Chem; 1998 May; 273(22):13870-7. PubMed ID: 9593733
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of human cytosolic phospholipase A2 by caspase-1 (ICE) and caspase-8 (FLICE).
Lüschen S; Ussat S; Krönke M; Adam-Klages S
Biochem Biophys Res Commun; 1998 Dec; 253(1):92-8. PubMed ID: 9875225
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes.
Dimitrov T; Krajcsi P; Hermiston TW; Tollefson AE; Hannink M; Wold WS
J Virol; 1997 Apr; 71(4):2830-7. PubMed ID: 9060638
[TBL] [Abstract][Full Text] [Related]
6. Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis.
Adam-Klages S; Schwandner R; Lüschen S; Ussat S; Kreder D; Krönke M
J Immunol; 1998 Nov; 161(10):5687-94. PubMed ID: 9820550
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2.
Wu YL; Jiang XR; Lillington DM; Allen PD; Newland AC; Kelsey SM
Cancer Res; 1998 Feb; 58(4):633-40. PubMed ID: 9485014
[TBL] [Abstract][Full Text] [Related]
8. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity.
Wright SC; Schellenberger U; Wang H; Kinder DH; Talhouk JW; Larrick JW
J Exp Med; 1997 Oct; 186(7):1107-17. PubMed ID: 9314559
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1.
Thommesen L; Sjursen W; Gåsvik K; Hanssen W; Brekke OL; Skattebøl L; Holmeide AK; Espevik T; Johansen B; Laegreid A
J Immunol; 1998 Oct; 161(7):3421-30. PubMed ID: 9759860
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
11. Need for caspases in apoptosis of trophic factor-deprived PC12 cells.
Haviv R; Lindenboim L; Li H; Yuan J; Stein R
J Neurosci Res; 1997 Oct; 50(1):69-80. PubMed ID: 9379495
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
Nyormoi O; Wang Z; Doan D; Ruiz M; McConkey D; Bar-Eli M
Mol Cell Biol; 2001 Aug; 21(15):4856-67. PubMed ID: 11438643
[TBL] [Abstract][Full Text] [Related]
13. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis.
Na S; Chuang TH; Cunningham A; Turi TG; Hanke JH; Bokoch GM; Danley DE
J Biol Chem; 1996 May; 271(19):11209-13. PubMed ID: 8626669
[TBL] [Abstract][Full Text] [Related]
14. Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.
Inayat-Hussain SH; Couet C; Cohen GM; Cain K
Hepatology; 1997 Jun; 25(6):1516-26. PubMed ID: 9185777
[TBL] [Abstract][Full Text] [Related]
15. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.
Foghsgaard L; Jäättelä M
J Virol; 1997 Oct; 71(10):7509-17. PubMed ID: 9311830
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis.
Hasegawa J; Kamada S; Kamiike W; Shimizu S; Imazu T; Matsuda H; Tsujimoto Y
Cancer Res; 1996 Apr; 56(8):1713-8. PubMed ID: 8620480
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B mediates tumor necrosis factor-induced arachidonic acid release in tumor cells.
Foghsgaard L; Lademann U; Wissing D; Poulsen B; Jaattela M
J Biol Chem; 2002 Oct; 277(42):39499-506. PubMed ID: 12185082
[TBL] [Abstract][Full Text] [Related]
18. Potentiation by vitamin D analogs of TNFalpha and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2.
Pirianov G; Danielsson C; Carlberg C; James SY; Colston KW
Cell Death Differ; 1999 Sep; 6(9):890-901. PubMed ID: 10510471
[TBL] [Abstract][Full Text] [Related]
19. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases.
Jones RA; Johnson VL; Buck NR; Dobrota M; Hinton RH; Chow SC; Kass GE
Hepatology; 1998 Jun; 27(6):1632-42. PubMed ID: 9620337
[TBL] [Abstract][Full Text] [Related]
20. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells.
Wu YL; Jiang XR; Newland AC; Kelsey SM
J Immunol; 1998 Jun; 160(12):5929-35. PubMed ID: 9637506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
